Gold Medalists To Receive Awards At ASTRO's Annual Meeting: September 23, 2008 The American Society for Therapeutic Radiology has selected the recipients of the 2008 Gold Medal, the highest honor that ASTRO bestows. Christopher Rose, M.D., FASTRO, and Joel Tepper, M.D., FASTRO, will be presented with their awards during ASTRO's 50th Annual Meeting in Boston during the Gold Medal Ceremony held on Tuesday, September 23, at 10:00 a.m.
Source: www.medicalnewstoday.comFlorida State University Chemist Receives $1.4-Million Grant To Study Obesity-Diabetes Link A Florida State University researcher has received a major scientific grant to study the chemical processes within the human body that may lead to the development of diabetes.
Source: www.medicalnewstoday.comFormed Think-Tank Seeks To Raise Awareness Among Healthcare Providers Of Underlying Neurobiological Link Between Various Disorders A coalition of
healthcare professionals have formed the Integrative Neurobiology Educational Alliance (INEA), a think-tank of national thought leaders who identify key educational gaps and needs from a neurobiological perspective.
Source: www.medicalnewstoday.comJournal Of Pharmaceutical Innovation Publishes Ground-breaking Scientific Papers On Reshaping Pharmaceutical Quality The June 2008 issue of the Journal of Pharmaceutical Innovation (JPI) is publishing the first scientific papers outlining the progress made on ISPE's Product Quality Lifecycle Implementation (PQLI) initiative.
Source: www.medicalnewstoday.comDiabeties And Fatty Liver Linked To Increased Risk Of Kidney Disease For patients with type 2 diabetes, a condition called non-alcoholic fatty liver disease (NAFLD) may be an important risk factor for diabetes-related chronic kidney disease (CKD), according to a study in the August Journal of the American Society of Nephrology (JASN).
Source: www.medicalnewstoday.comAVEO Pharmaceuticals Completes Enrollment In Phase 2 Clinical Trial Of AV-951 In Patients With Metastatic Renal Cell Carcinoma AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that they have completed enrollment in their 200-patient Phase 2 clinical trial of AV-951 in patients with metastatic renal cell carcinoma (mRCC).
Source: www.medicalnewstoday.comAnabolic-Androgenic Steroid Abuse - Are Ya Juicin' It? http://hotmedicalnews.com - Irritable, angry, aggressive, but feeling strong and invincible, Mr. A, 32, a bodybuilder and prison guard, stopped at a convenience store to call his boss. Car trouble on the way to work.. He would be late. Mr.
Source: www.medicalnewstoday.comCatumaxomab, Representing A New Generation Of Antibodies, Proved Efficient And Safe In Malignant Ascites Treatment with the trifunctional antibody catumaxomabsignificantly prolongs puncture-free survival in patients with malignantascites, according to the results from a Phase II/III trial presented at the44th American Society of Clinical Oncology (ASCO) congress.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 6:00 PM
